Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Masaaki Miyauchi
Observed names:
M. Miyauchi,
Miyauchi, Masaaki
Institutions:
Tokyo Medical University,
Tokyo Medical University Hachioji Medical Center
Observed institutions:
Tokai University,
Tokyo Medical University,
Tokyo Medical University Hachioji Medical Center,
Tokai University Hospital,
Isehara Kyodo Hospital
ORCID:
0000-0003-4838-5344
Observed ORCID:
0000-0003-4838-5344
OpenAlex ID:
A5038084147
Effects of Liraglutide, a Human Glucagon-like Peptide-1 Analogue, on Body Weight, Body Fat Area and Body Fat-related Markers in Patients with Type 2 Diabetes Mellitus
2013
·
Daisuke Suzuki
, Masao Toyoda
, et al.
·
Internal Medicine
·
61
PDF
Glomerular expression of CTGF, TGF-beta 1 and type IV collagen in diabetic nephropathy.
2007
·
Tomoya Umezono
, Masao Toyoda
, et al.
·
PubMed
·
51
Relationship between the Expression of Advanced Glycation End-Products (AGE) and the Receptor for AGE (RAGE) mRNA in Diabetic Nephropathy
2006
·
Daisuke Suzuki
, Masao Toyoda
, et al.
·
Internal Medicine
·
50
PDF
Hypertrophy and Loss of Podocytes in Diabetic Nephropathy
2009
·
Masaaki Miyauchi
, Masao Toyoda
, et al.
·
Internal Medicine
·
42
PDF
Upregulation ofα3β1-Integrin in Podocytes in Early-Stage Diabetic Nephropathy
2016
·
Kaichiro Sawada
, Masao Toyoda
, et al.
·
Journal of Diabetes Research
·
29
PDF
Exercise Therapy for Management of Type 2 Diabetes Mellitus: Superior Efficacy of Activity Monitors over Pedometers
2016
·
Masaaki Miyauchi
, Masao Toyoda
, et al.
·
Journal of Diabetes Research
·
28
PDF
Lectin-Like Oxidized LDL Receptor-1 (LOX-1) Expression in the Tubulointerstitial Area Likely Plays an Important Role in Human Diabetic Nephropathy
2009
·
Naoyuki Yamamoto
, Masao Toyoda
, et al.
·
Internal Medicine
·
28
PDF
Expression of transcription factor Snai1 and tubulointerstitial fibrosis in progressive nephropathy
2011
·
Keiko Ohnuki
, Tomoya Umezono
, et al.
·
Journal of Nephrology
·
25
Expression of Alpha-actinin-4 in Human Diabetic Nephropathy
2008
·
Moritsugu Kimura
, Masao Toyoda
, et al.
·
Internal Medicine
·
20
PDF
Nivolumab‐induced fulminant type 1 diabetes with precipitous fall in C‐peptide level
2019
·
Masaaki Miyauchi
, Masao Toyoda
, et al.
·
Journal of Diabetes Investigation
·
16
PDF
Insulin glargine improves glycemic control and quality of life in type 2 diabetic patients on hemodialysis
2012
·
Masao Toyoda
, Moritsugu Kimura
, et al.
·
Journal of Nephrology
·
15
Efficacy of long-acting insulin analog insulin glargine at high dosage for basal-bolus insulin therapy in patients with type 2 diabetes.
2012
·
Daisuke Suzuki
, Masao Toyoda
, et al.
·
PubMed
·
12
Influence of the combination of SGLT2 inhibitors and GLP-1 receptor agonists on eGFR decline in type 2 diabetes: post-hoc analysis of RECAP study
2024
·
Yoshimi Muta
, Kazuo Kobayashi
, et al.
·
Frontiers in Pharmacology
·
11
PDF
An investigation of 2,093 renal biopsies performed at Tokai University Hospital between 1976 and 2000
2008
·
M. Honma
, M. Toyoda
, et al.
·
Clinical Nephrology
·
10
Renoprotective effects of combination treatment with sodium-glucose cotransporter inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus according to preceding medication
2023
·
Kazuo Kobayashi
, Masao Toyoda
, et al.
·
Diabetes and Vascular Disease Research
·
9
Atypical Ketoacidosis and Protracted Hyperglycosuria after Treatment with Ipragliflozin, an SGLT2 Inhibitor
2017
·
Masaaki Miyauchi
, Masao Toyoda
, et al.
·
Internal Medicine
·
9
PDF
Effect of preceding drug therapy on the renal and cardiovascular outcomes of combined sodium‐glucose cotransporter‐2 inhibitor and glucagon‐like peptide ‐1 receptor agonist treatment in patients with type 2 diabetes and chronic kidney disease
2024
·
RECAP study group
, Shunichiro Tsukamoto
, et al.
·
Diabetes Obesity and Metabolism
·
8
PDF
Effectiveness of basal-supported oral therapy (BOT) using insulin glargine in patients with poorly controlled type 2 diabetes.
2012
·
Daisuke Suzuki
, Tomoya Umezono
, et al.
·
PubMed
·
8
A Retrospective Study on the Efficacy of Corticosteroid-Alone Therapy in Membranous Nephropathy Patients
2007
·
Moritsugu Kimura
, Masao Toyoda
, et al.
·
Internal Medicine
·
3
PDF
The concomitant use of sodium-glucose co-transporter 2 inhibitors improved the renal outcome of Japanese patients with type 2 diabetes treated with glucagon-like peptide 1 receptor agonists
2023
·
Kazuo Kobayashi
, Masao Toyoda
, et al.
·
Cardiovascular Endocrinology & Metabolism
·
2
Detection of Autonomic Nervous System Abnormalities in Diabetic Patients by 24-hour Ambulatory Blood Pressure Monitoring.
2018
·
Moritsugu Kimura
, Masao Toyoda
, et al.
·
PubMed
·
2
Long-term glycemic control in Japanese type 2 diabetes patients after switching treatment from twice-daily premixed insulin to once daily insulin glargine.
2013
·
Tomoya Umezono
, Daisuke Suzuki
, et al.
·
PubMed
·
2
Intensive insulin therapy for Japanese patients with type 2 diabetes mellitus--results in the patients from single hospital.
2008
·
Masao Toyoda
, Tomoya Umezono
, et al.
·
PubMed
·
2
Long-Term Intensive Insulin Therapy for Japanese Patients with Type 2 Diabetes Mellitus
2008
·
Tomoya Umezono
, Masao Toyoda
, et al.
·
Internal Medicine
·
2
PDF
[Case of rheumatoid arthritis with various histological lesions of the kidney].
2006
·
Masashi Honma
, Masao Toyoda
, et al.
·
PubMed
·
1
Show more works
View as search
Works count:
34
Citation count:
447
H-index:
12
I10-index:
14
Year
Topic
Type
